Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Cole Hugh M, Directeur Commercial. Officer active across 1 company, notably Jounce Therapeutics, Inc.. Aggregated, 4 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €30k. Activity tracked since 7 January 2022. The latest transaction was disclosed on 9 January 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Hugh M. Cole is the Chief Business Officer of Jounce Therapeutics, Inc. He is responsible for business strategy and partnership development. With significant experience in the biopharmaceutical industry, he plays a key role in expanding Jounce's operations and achieving its growth objectives.